Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer

Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer

Objectives18F-fluorodeoxyglucose (FDG) PET/CT has been widely used in tumor diagnosis, staging, and response evaluation. To determine an optimal therapeutic strategy for lung cancer patients, accurate staging is essential. Semi-quantitative standardized uptake value (SUV) is known to be affected by...

Full description

Bibliographic Details
Main Authors: Xieraili Wumener, Yarong Zhang, Zhenguo Wang, Maoqun Zhang, Zihan Zang, Bin Huang, Ming Liu, Shengyun Huang, Yong Huang, Peng Wang, Ying Liang, Tao Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
dynamic imaging
PET/CT
18F-FDG
lung cancer
lymph Node
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1005924/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1005924/full

Similar Items